|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments (includes $0 and $340 of available-for-sale securities as of December 31, 2023 and 2022, respectively, reported at fair value) | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, less allowance for credit losses of $1,560 and $1,318 as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Inventory, net | ||||||||||||||||||||
| Income tax receivable | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Short-term investments - deferred compensation | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangibles assets, net | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Long-term investments | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST AND EQUITY | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Revolving credit agreement outstanding | ||||||||||||||||||||
| Unearned revenue | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Accrued wages and benefits | ||||||||||||||||||||
| Deferred compensation liability | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Non-current revolving credit agreement | ||||||||||||||||||||
| Non-current convertible senior notes, net of debt issuance costs | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Non-current unearned revenue | ||||||||||||||||||||
| Non-current pension liability | ||||||||||||||||||||
| Non-current deferred compensation liability | ||||||||||||||||||||
| Non-current lease obligations | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Redeemable Non-Controlling Interest | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Common stock, par value $0.01 per share; 200,000 shares authorized; 81,453 shares issued and 81,195 outstanding as of June 30, 2026 and 80,188 shares issued and 79,926 outstanding as of December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Retained deficit | ||||||||||||||||||||
| Less treasury stock at cost: 258 and 262 shares as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Total Equity | ||||||||||||||||||||
| Total Liabilities, Redeemable Non-Controlling Interest and Equity | ||||||||||||||||||||
Loading...
